Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: AOH1996 for the Treatment of Refractory Solid Tumors [Phase 1]

View source ↗

Summary

AOH1996 is being studied in a Phase 1 trial for patients with refractory solid tumors, including osteosarcoma and several other sarcomas and solid cancers, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AOH1996

Snippet

Sponsor: City of Hope Medical Center | Conditions: Refractory Malignant Solid Neoplasm, Osteosarcoma | Phase 1 | Status: RECRUITING